Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Obstructive Lung Diseases

Free Subscription Articles published in J Investig Allergol Clin Immunol Retrieve available abstracts of 34 articles: HTML format

Single Articles

June 2026
1. MASPERO JF, Gupta A, Schmidt O, Perez de Llano LA, et al
   Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Moderate-to-Severe Asthma, Type 2 Inflammation, and Nocturnal Awakenings: The MORPHEO Randomized Controlled Trial.
   J Investig Allergol Clin Immunol. 2026 Jun 29:0. doi: 10.18176/jiaci.1160.
   PubMed     Abstract available
   
   
   May 2026
2. LEONHARDT J, Gaedtke L, Alkan GH, Hermann S, et al
   Eosinophilic Pleural Effusion Following Long-Term Asthma Remission Under Dupilumab Therapy: A Search for Clues Using Cytokine Analyses.
   J Investig Allergol Clin Immunol. 2026 May 13:0. doi: 10.18176/jiaci.1184.
   PubMed    
   
   
   
3. DACAL RIVAS D, Blanco Cid N, Perez Ortiz D, Mosteiro Anon M, et al
   A Retrospective Multicenter Cohort Study on the Effectiveness of Triple Inhaled Therapy in Severe Asthma.
   J Investig Allergol Clin Immunol. 2026 May 5:0. doi: 10.18176/jiaci.1181.
   PubMed     Abstract available
   
   
   April 2026
4. SANZ-SANJOSE B, Laorden D, Romero D, De Las Vecillas L, et al
   Tezepelumab in Allergic Bronchopulmonary Aspergillosis With Severe Uncontrolled Asthma: A Retrospective 4-Case Series.
   J Investig Allergol Clin Immunol. 2026 Apr 22:0. doi: 10.18176/jiaci.1173.
   PubMed    
   
   
   
5. BAPTISTA-SERNA L, De Las Heras-Gozalo M, Korshunova D, Santano E, et al
   Vitellogenin Identified as a Novel Allergen in Tenebrio molitor: Evidence from an Occupational Asthma Case.
   J Investig Allergol Clin Immunol. 2026 Apr 17:0. doi: 10.18176/jiaci.1175.
   PubMed    
   
   
   
6. ALMONACID C, Davila I, Plaza V, Dominguez-Ortega J, et al
   Artificial Intelligence in Asthma: From Diagnosis to Management.
   J Investig Allergol Clin Immunol. 2026 Apr 10:0. doi: 10.18176/jiaci.1171.
   PubMed     Abstract available
   
   
   March 2026
7. IZAGUIRRE-FLORES H, Arismendi E, Martin-Ruiz de la Rosa E, Roman-Bernal B, et al
   Real-World Experience With Dupilumab in Severe Asthma: The Spanish Multicenter Study DUPImpact.
   J Investig Allergol Clin Immunol. 2026 Mar 30:0. doi: 10.18176/jiaci.1156.
   PubMed     Abstract available
   
   
   
8. CREMADES-JIMENO L, Lopez-Ramos M, Baos S, Fernandez-Santamaria R, et al
   Development of a Panel of Molecular Biomarkers of Asthma: Analysis of Differential Expression and Stability Over Time.
   J Investig Allergol Clin Immunol. 2026 Mar 26:0. doi: 10.18176/jiaci.1168.
   PubMed     Abstract available
   
   
   January 2026
9. LOPEZ-GONZALEZ P, Vazquez de la Torre M, Garcia-Moguel I, Juarez Rodriguez C, et al
   Severe Asthma and Chronic Rhinosinusitis With Nasal Polyps: Simultaneous Response to Dupilumab.
   J Investig Allergol Clin Immunol. 2026 Jan 13:0. doi: 10.18176/jiaci.1150.
   PubMed    
   
   
   December 2025
10. DEVILLIER P, Demoly P, Bergmann JF, Delaisi B, et al
    Impact of Liquid Sublingual Immunotherapy on Health Care Resource Use in Allergic Rhinitis and Asthma in the Real-world EfficAPSI Study.
    J Investig Allergol Clin Immunol. 2025 Dec 11:0. doi: 10.18176/jiaci.1142.
    PubMed     Abstract available
    
    
    
11. SOLER-SEGOVIA D, Romero-Mesones C, Espejo D, Pilia F, et al
    Inflammatory and Immune Effects of Pollution: Comparison Between Patients With Asthma and Healthy Individuals.
    J Investig Allergol Clin Immunol. 2025 Dec 4:0. doi: 10.18176/jiaci.1094.
    PubMed     Abstract available
    
    
    
12. MORENO-CONDE A, Moreno-Conde J, Guardia-Martinez P, Vilches-Arenas A, et al
    Prevalence, Treatment Trajectories, and Environmental Exacerbation Factors in Asthma: A Regional Study in Andalusia.
    J Investig Allergol Clin Immunol. 2025 Dec 3:0. doi: 10.18176/jiaci.1096.
    PubMed     Abstract available
    
    
    November 2025
13. GALVAN CA, Duran R, Quirce S
    A Critical Review of Occupational Asthma in the 21st Century Work Environment.
    J Investig Allergol Clin Immunol. 2025 Nov 5:0. doi: 10.18176/jiaci.1123.
    PubMed     Abstract available
    
    
    October 2025
14. ESTRAVIS M, Carreiras-Quintas D, Trivino JC, Perez-Pazos J, et al
    Identification of Dual Super-Response in Patients With Asthma and CRSwNP Treated With Mepolizumab.
    J Investig Allergol Clin Immunol. 2025 Oct 24:0. doi: 10.18176/jiaci.1102.
    PubMed     Abstract available
    
    
    July 2025
15. SALDANA-PEREZ LE, Serrano Pariente J, Cisneros Serrano C, Plaza V, et al
    Dynamic Hyperinflation in Patients With Moderate-Severe Asthma: Relationship With Clinical Control and Small Airway Dysfunction.
    J Investig Allergol Clin Immunol. 2025 Jul 30:0. doi: 10.18176/jiaci.1088.
    PubMed     Abstract available
    
    
    April 2025
16. CALZADA D, Bartra J, Serrano CD, Riggioni S, et al
    Differences in Molecular Sensitization Profiles Between Spanish and Latin American Mite-Allergic Patients.
    J Investig Allergol Clin Immunol. 2025;35:114-121.
    PubMed     Abstract available
    
    
    March 2025
17. GARCIA-RIO F
    The Evolving Role of Lung Function Interpretation: Clinical Implications of the new ERS/ATS Standards in Asthma Care.
    J Investig Allergol Clin Immunol. 2025 Mar 14:0. doi: 10.18176/jiaci.1084.
    PubMed     Abstract available
    
    
    
18. BANTULA M, Garcia A, Picado C, Arismendi E, et al
    Obese Asthma Syndrome: Multiple Inflammatory Patterns and A Key Solution.
    J Investig Allergol Clin Immunol. 2025 Mar 5:0. doi: 10.18176/jiaci.1071.
    PubMed    
    
    
    January 2025
19. SOUSA-PINTO B, Savoure M, Vieira RJ, Amaral R, et al
    Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users.
    J Investig Allergol Clin Immunol. 2025 Jan 23:0. doi: 10.18176/jiaci.1047.
    PubMed     Abstract available
    
    
    November 2024
20. OJANGUREN I, Quirce S, Bobolea I, Perez de Llano L, et al
    Phenotyping Asthma Exacerbations: One Step Further in the Management of Severe Asthma.
    J Investig Allergol Clin Immunol. 2024 Nov 28:0. doi: 10.18176/jiaci.1043.
    PubMed     Abstract available
    
    
    
21. MASCARO-HEREZA B, Loli-Ausejo D, Valero A, Arismendi E, et al
    Effectiveness of Biologics in Patients With Severe Asthma and Psychiatric Comorbidities.
    J Investig Allergol Clin Immunol. 2024 Nov 27:0. doi: 10.18176/jiaci.1034.
    PubMed    
    
    
    
22. RIAL MJ, Betancor D, Canas JA, Olaguibel JM, et al
    Stability of Asthma Phenotypes in the Spanish Cohort of the MEGA Project.
    J Investig Allergol Clin Immunol. 2024 Nov 25:0. doi: 10.18176/jiaci.1026.
    PubMed    
    
    
    
23. MIRALLES-LOPEZ JC, Andujar-Espinosa R, Bravo-Gutierrez FJ, Cabrejos-Perotti S, et al
    Tezepelumab in Patients With Severe Asthma: Response at 3 Months.
    J Investig Allergol Clin Immunol. 2024 Nov 25:0. doi: 10.18176/jiaci.1041.
    PubMed    
    
    
    
24. OZDEMIR O
    Occupational Asthma and Rhinoconjunctivitis due to Soybean in a Bakery Worker.
    J Investig Allergol Clin Immunol. 2024 Nov 13:0. doi: 10.18176/jiaci.1035.
    PubMed    
    
    
    
25. LOZANO-ESPINOSA M, Rodriguez-Otero N, Antolin-Amerigo D, Gordo Vidal F, et al
    Characteristics of Asthma Patients Admitted to the Intensive Care Unit of a Tertiary University Hospital in Madrid, Spain: A 5-Year Experience.
    J Investig Allergol Clin Immunol. 2024 Nov 12:0. doi: 10.18176/jiaci.1021.
    PubMed    
    
    
    October 2024
26. POLA-BIBIAN B, Dominguez-Ortega J, Vila-Nadal G, Entrala A, et al
    Asthma Exacerbations in a Tertiary Hospital: Clinical Features, Triggers, and Risk Factors for Hospitalization.
    J Investig Allergol Clin Immunol. 2024;27:238-245.
    PubMed     Abstract available
    
    
    
27. PLAZA V, Eguiluz I, Garin N, Martinez Moragon E, et al
    EPI-SURVEY: Grade of Awareness Among Spanish Allergists, Hospital Pharmacists, and Pulmonologists of the Relevance of Bronchial Epithelium and Alarmins in the Pathogenesis and Management of Severe Asthma.
    J Investig Allergol Clin Immunol. 2024;34:336-338.
    PubMed    
    
    
    July 2024
28. VENEGAS GARRIDO C, Nair P, Davila I, Perez de Llano L, et al
    Role of Thymic Stromal Lymphopoietin in the Pathophysiology of Asthma and Clinical and Biological Effects of Blockade With Tezepelumab.
    J Investig Allergol Clin Immunol. 2024 Jul 26:0. doi: 10.18176/jiaci.1012.
    PubMed     Abstract available
    
    
    June 2024
29. BETANCOR D, Otal M, Olaguibel JM, Rodrigo-Munoz JM, et al
    Global Lung Initiative as Diagnostic Criteria in Asthma-COPD Overlap Syndrome: Prevalence and Disease Characterization in a Real-Life Asthma Cohort.
    J Investig Allergol Clin Immunol. 2024;34:192-195.
    PubMed    
    
    
    
30. ZAKZUK J, Donado K, Mondol E, Marrugo V, et al
    IgE-Mediated Sensitization to Blo t 21 and Blo t 5 Is Associated With Asthma in the Tropics: A Case-Control Study.
    J Investig Allergol Clin Immunol. 2024;34:157-166.
    PubMed     Abstract available
    
    
    May 2024
31. SOUSA-PINTO B, Fonseca JA, Bousquet J
    Contribution of MASK-air(R) as a mHealth tool for digitally-enabled person-centred care in rhinitis and asthma.
    J Investig Allergol Clin Immunol. 2024 May 14:0. doi: 10.18176/jiaci.0994.
    PubMed     Abstract available
    
    
    
32. TOMAS-PEREZ M, Trisan Alonso A, Montoro-Ferrer A, Dominguez-Ortega J, et al
    Concomitant Efficacy of Dupilumab in Treating Eosinophilic Esophagitis and Type 2 Asthma.
    J Investig Allergol Clin Immunol. 2024 May 9:0. doi: 10.18176/jiaci.1011.
    PubMed    
    
    
    April 2024
33. DE LAS VECILLAS L, Quirce S
    The Multiple Trajectories of the Allergic March.
    J Investig Allergol Clin Immunol. 2024;34:75-84.
    PubMed     Abstract available
    
    
    February 2024
34. SOUSA-PINTO B, Palamarchuk Y, Leemann L, Jankin S, et al
    From MASK-air and SILAM to CATALYSE (Climate Action To Advance HeaLthY Societies in Europe).
    J Investig Allergol Clin Immunol. 2024;34:12-19.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum